Over the 90-day window ending February 19, 2026, Emergent BioSolutions's three dominant insider ownership positions are held by President And Ceo Robert Kramer (506.06K shares), President And Ceo Joseph C Papa (342.50K shares), Evp And Chief Financial Officer Richard S Lindahl (239.70K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Robert Kramer | President And Ceo | 506,059 | 13 Jun, 2023 |
| Joseph C Papa | President And Ceo | 342,500 | 15 May, 2025 |
| Richard S Lindahl | Evp And Chief Financial Officer | 239,700 | 10 Feb, 2026 |
| Fuad El-Hibri | 206,434 | 07 Dec, 2021 | |
| Jennifer Lynne Fox | Evp And Ext Aff And Gc And Corp Sec | 186,382 | 12 Jul, 2024 |
| Adam Havey | Evp And Business Operations | 174,398 | 13 Jun, 2023 |
| Louis W Sullivan | 139,098 | 02 May, 2025 | |
| Neal Franklin Fowler | 135,503 | 02 May, 2025 | |
| Zsolt Harsanyi | Chairman | 123,732 | 02 May, 2025 |
| Donald W Degolyer | 119,858 | 12 Nov, 2025 | |
| Coleen Glessner | Evp And Quality & Ethics And And Cpl | 112,620 | 10 Feb, 2026 |
| Ronald Richard | 98,417 | 09 Dec, 2025 | |
| William Hartzel | Svp And Bioservices | 96,681 | 10 Feb, 2026 |
| Sujata Tyagi Dayal | 88,980 | 10 Nov, 2025 | |
| Marvin L White | 88,495 | 02 May, 2025 | |
| Simon C Lowry | Svp And R&D And Cmo | 88,439 | 16 Dec, 2025 |
| Atul Saran | Evp And Chief Strat & Dev Officer | 86,645 | 02 Mar, 2023 |
| Keith Katkin | 86,431 | 28 May, 2025 | |
| Paul Anthony Williams | Svp And Products Business | 76,194 | 10 Feb, 2026 |
| Kathryn C Zoon | 71,799 | 18 Aug, 2025 | |
| Jessica Perl | Svp And General Counsel And Corp Sec | 67,469 | 10 Feb, 2026 |
| Katherine Strei | Evp And Chief Hr Officer | 62,824 | 02 Mar, 2023 |
| Jerome M Hauer | 57,508 | 30 May, 2023 | |
| George A Joulwan | 40,244 | 31 May, 2022 | |
| Sean Kirk | Evp And Manufacturing & Tech Ops | 17,776 | 01 Apr, 2021 |
| Karen L. Smith | Evp And Chief Medical Officer | 11,888 | 11 May, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Feb, 2026 | Jessica Perl | Common Stock | D | 918 | $11.03 | 67,469 | D | F |
| 06 Feb, 2026 | Richard S Lindahl | Common Stock | D | 46,155 | $10.92 | 245,342 | D | D |
| 06 Feb, 2026 | Richard S Lindahl | Common Stock | D | 5,642 | $10.92 | 239,700 | D | F |
| 06 Feb, 2026 | Coleen Glessner | Common Stock | D | 2,852 | $10.92 | 112,620 | D | F |
| 06 Feb, 2026 | Coleen Glessner | Common Stock | D | 28,847 | $10.92 | 115,472 | D | D |
| 06 Feb, 2026 | Paul Anthony Williams | Common Stock | D | 8,655 | $10.92 | 77,216 | D | D |
| 06 Feb, 2026 | Paul Anthony Williams | Common Stock | D | 1,022 | $10.92 | 76,194 | D | F |
| 06 Feb, 2026 | William Hartzel | Common Stock | D | 630 | $10.92 | 96,681 | D | F |
| 06 Feb, 2026 | William Hartzel | Common Stock | D | 5,771 | $10.92 | 97,311 | D | D |
| 14 Dec, 2025 | Simon C Lowry | - | - | 88,439 | D | |||
| 14 Dec, 2025 | Simon C Lowry | Common Stock | D | 3,543 | $11.41 | 88,439 | D | F |
| 05 Dec, 2025 | Ronald Richard | - | - | 113,301 | D | |||
| 05 Dec, 2025 | Ronald Richard | Common Stock | A | 25,748 | $5.02 | 124,165 | D | M |
| 05 Dec, 2025 | Ronald Richard | Common Stock | D | 14,884 | $11.90 | 98,417 | D | S |
| 05 Dec, 2025 | Ronald Richard | - | - | 124,165 | D | |||
| 05 Dec, 2025 | Ronald Richard | - | - | 98,417 | D | |||
| 05 Dec, 2025 | Ronald Richard | Common Stock | D | 10,864 | $11.90 | 113,301 | D | F |
| 05 Dec, 2025 | Ronald Richard | Common Stock | D | 7,100 | $12.11 | 98,417 | D | S |
| 05 Dec, 2025 | Ronald Richard | - | - | 98,417 | D | |||
| 11 Nov, 2025 | William Hartzel | Common Stock | D | 610 | $10.88 | 103,082 | D | F |